Krystal Biotech, Inc. (KRYS)
324.55
+3.13
(+0.97%)
USD |
NASDAQ |
Oct 29, 16:00
334.33
+9.78
(+3.01%)
After-Hours: 20:00
Krystal Biotech Total Return Level : 324.55 for Oct. 29, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 29, 2026 | 324.55 |
| October 28, 2026 | 321.42 |
| October 27, 2026 | 320.58 |
| October 26, 2026 | 313.66 |
| October 23, 2026 | 311.50 |
| October 22, 2026 | 320.13 |
| October 21, 2026 | 322.17 |
| October 20, 2026 | 325.42 |
| October 19, 2026 | 320.25 |
| October 16, 2026 | 316.58 |
| October 15, 2026 | 330.00 |
| October 14, 2026 | 330.69 |
| October 13, 2026 | 321.16 |
| October 12, 2026 | 332.07 |
| October 09, 2026 | 331.61 |
| October 08, 2026 | 327.30 |
| October 07, 2026 | 324.57 |
| October 06, 2026 | 326.81 |
| October 05, 2026 | 334.85 |
| October 02, 2026 | 322.28 |
| October 01, 2026 | 325.31 |
| September 30, 2026 | 332.56 |
| September 29, 2026 | 335.06 |
| September 28, 2026 | 337.08 |
| September 25, 2026 | 345.82 |
| Date | Value |
|---|---|
| September 24, 2026 | 344.96 |
| September 23, 2026 | 341.75 |
| September 22, 2026 | 350.88 |
| September 21, 2026 | 333.85 |
| September 18, 2026 | 336.67 |
| September 17, 2026 | 338.75 |
| September 16, 2026 | 336.67 |
| September 15, 2026 | 336.68 |
| September 14, 2026 | 340.03 |
| September 11, 2026 | 347.00 |
| September 10, 2026 | 345.55 |
| September 09, 2026 | 348.09 |
| September 08, 2026 | 351.26 |
| September 04, 2026 | 358.24 |
| September 03, 2026 | 371.47 |
| September 02, 2026 | 369.23 |
| September 01, 2026 | 363.84 |
| August 31, 2026 | 359.36 |
| August 28, 2026 | 351.46 |
| August 27, 2026 | 357.46 |
| August 26, 2026 | 359.76 |
| August 25, 2026 | 356.19 |
| August 24, 2026 | 341.72 |
| August 21, 2026 | 346.58 |
| August 20, 2026 | 337.02 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| TG Therapeutics, Inc. | 58.08 |
| Alnylam Pharmaceuticals, Inc. | 174.00 |
| Cytokinetics, Inc. | 63.31 |
| Ionis Pharmaceuticals, Inc. | 44.39 |
| Regeneron Pharmaceuticals, Inc. | 826.36 |